Disease Info Card

Intracranial Meningioma

Information about Intracranial Meningioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Intracranial Meningioma

Most recent studies have shown that Intracranial Meningioma shares some biological mechanisms with benign-meningioma, brain-edema, brain-neoplasms, carcinoma, edema, headache, hemorrhage, intracranial-neoplasm, lung-neoplasms, malignant-meningioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, meningeal-neoplasms, meningioma, neoplasm-invasiveness, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neoplasms-multiple-primary, peritumoural-oedema.

Among the many pathways, these few ones have gauged particular interests from scientists studying Intracranial Meningioma, and have been seen in publications frequently: Aging, Angiogenesis, Cell Adhesion, Cell Cycle, Cell Growth, Cell Proliferation, Coagulation, Dedifferentiation, Glial Cell Proliferation, Hemostasis, Interphase, Invasive Growth, Localization, Mitosis, Muscle Atrophy, Oncogenesis, Pathogenesis, Reflex, Transport

Quite a number of genes have been found to play important roles in Intracranial Meningioma, such as ARSA, CSF2, ESR1, F2R, LAMC2, MUC1, NF2, NLRP5, PCNA, PGR, TFRC, TGM1, TMEM37, TP53, VEGFA, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.